Pharmaceutical Executive Collapses During Trump’s Oval Office Drug Price Announcement
Key Takeaways
- A pharmaceutical executive, reportedly Gordon Findlay of Novo Nordisk, collapsed during the Oval Office event.
- The collapse occurred amid President Trump’s announcement of new deals to lower weight-loss drug prices.
- White House medical staff and Dr. Mehmet Oz responded immediately; the man was reported to be fine.
White House Drug Price Event Incident
A White House event on November 6, 2025, announcing price reductions for GLP-1 weight-loss drugs was briefly halted when a man standing behind former President Donald Trump collapsed in the Oval Office.
“Auto news: Can you break the speed limit when you're merging or overtaking”
Multiple outlets report that Dr. Mehmet Oz and officials quickly assisted the individual, the press was ushered out, and the White House Medical Unit later said he was okay.
Coverage consistently notes the event was centered on deals with Eli Lilly and Novo Nordisk to lower costs and expand access.
Trump later told reporters the man was fine and receiving care before the event resumed.
Conflicting Reports on Identity
Confusion over the man’s identity fueled online speculation.
Several tabloids and some outlets named him as Novo Nordisk executive Gordon Findlay, while multiple mainstream reports say the company denied he was present.
LiveNOW from FOX reports Novo Nordisk clarified Findlay was not at the event.
International Business Times UK reports the company “confirmed” he was not present.
Primetimer notes the initial identification was not confirmed.
In contrast, Daily Express, Daily Star, and Futurism assert he was Gordon Findlay, with Futurism even describing him as the company’s U.S. executive VP—claims at odds with the company’s clarification.
Other coverage, like Free Press Journal and Telegrafi, hedged with language such as “possibly” or “believed to be” while noting a lack of official confirmation.
Affordable GLP-1 Drug Plans
The announcement focused on making costly GLP-1 drugs more affordable through a combination of price reductions, expanded coverage, and policy compromises.
“A White House event led by US President Donald Trump took an unexpected turn when a man standing behind him collapsed during the announcement of a new initiative to lower the cost of weight-loss drugs”
Sources differ on the specific mechanisms and timelines involved in these changes.
NDTV Profit reports a deal to lower monthly out-of-pocket costs from $500–$1,000 to an average of $149–$350.
Daily Mail states that some pills would be available for $149 with expanded Medicare access, in exchange for tariff relief on imported pharmaceuticals.
ABP Live English also mentions reduced prices offered in exchange for tariff relief.
DIE WELT adds that Trump promised lower import tariffs and faster drug approvals.
Meanwhile, ARY News describes the federal effort as using subsidies to expand access to these medications.
Several outlets mention a consumer website to facilitate access to discounted treatments.
Tribune Online refers to a new TrumpRx portal set to launch next year.
Daily Star and Daily Express report that discounted treatments would be offered via a new website launching in January 2026.
Media Reactions to Incident
Media depictions of the incident’s optics differ sharply.
Primetimer reports Trump immediately showed concern, rising from his chair.
In contrast, Irish Star says Trump remained motionless during the incident.
NewsBreak says he appeared frozen and showed little immediate reaction, though it also reports Dr. Oz later praised Trump for calling the man’s wife.
Coverage also varied on press access.
Entertainment Weekly notes the livestream ended as the press was cleared.
Daily Express US says Fox cut coverage abruptly.
ABP Live English says the event resumed about an hour later with Trump reassuring attendees.
Incident and Attendees Overview
There is no consensus on what caused the collapse.
“Washington: A man collapsed inside the Oval Office during an event where President Donald Trump announced a new initiative to provide subsidized access to weight-loss prescription drugs”
abcnews.go attributes it to standing too long in a warm room, while LiveNOW from FOX says the cause remains unknown.
Multiple outlets say the man recovered: Tribune Online and Telegrafi cite the White House saying he was okay, and ABP Live identifies him as “Gordon,” a guest of Eli Lilly, who was fine after examination by Dr. Oz.
Several sources also spotlight who attended: NDTV Profit, LiveNOW, and Irish Star note the presence of U.S. Health and Human Services Secretary Robert F. Kennedy Jr., with Irish Star adding he “appeared alarmed but quickly exited.”
Separately, ARY News uniquely ties the policy push to a broader trend, asserting U.S. obesity rates have recently declined, possibly linked to increased use of GLP-1 drugs.
More on Techonology and Science
Vice President JD Vance Pauses $259 Million in Medicaid Funding to Minnesota
16 sources compared
Surgeon Yaser Jabbar Botched Surgeries and Harmed Nearly 100 Children at Great Ormond Street Hospital, Independent Review Finds
15 sources compared
Airports Across Asia Ramp Up Health Screenings After India Confirms Two Nipah Virus Cases
41 sources compared
Trump Unveils Vague 'Great Healthcare Plan', Replacing Subsidies With Direct Payments Critics Warn Will Harm Low-Income Americans
29 sources compared